Relating to a report on governmental opioid antagonist programs to reverse and prevent opioid overdoses.
Summary
HB 4783 requires the Texas Health and Human Services Commission to produce a biennial report on governmental opioid antagonist programs, beginning no later than October 1 of each even-numbered year. The report must evaluate how opioid antagonists, such as naloxone, are being distributed across the state to reverse and prevent opioid overdoses and must be submitted to the governor, lieutenant governor, and speaker of the house.
The required report is broad and data-driven. It must include a needs assessment for opioid antagonist programs run by state agencies and institutions of higher education, establish a statewide saturation goal, describe the data and methodology used to identify supply gaps, outline a communications plan for high-risk overdose areas, summarize state and federal funding, identify distribution strategies, list existing purchase and distribution programs, and recommend improvements for high-risk populations including school-aged children, pregnant and postpartum women, and rural residents.
Impact
The bill does not directly create a new treatment program or mandate distribution of opioid antagonists; instead, it adds a reporting requirement to Chapter 461A of the Health and Safety Code. It expands the duties of the Health and Human Services Commission to coordinate with state agencies and institutions of higher education that receive resources for opioid antagonist distribution, and it formalizes state-level oversight of overdose prevention efforts. The practical effect is to improve legislative and executive visibility into funding, supply, distribution, and gaps in naloxone-related programs.
Sentiment
The available voting history suggests the bill was generally well received and moved with substantial support. The House third-reading vote was 137-10, and the House later concurred in Senate amendments by 112-24, indicating broad bipartisan approval despite some opposition. The committee reported the bill favorably as a substitute, and the Senate committee action was also favorable, reflecting overall agreement with the bill’s public health purpose.
Contention
The main point of contention appears to be not the goal of addressing opioid overdoses, but the scope and administrative burden of the reporting framework. Because the bill requires a statewide needs assessment, funding inventory, distribution strategy, and communications planning, any concerns likely centered on whether the commission should be tasked with producing a detailed recurring report and how much discretion it should have in defining saturation goals and identifying high-risk populations. The recorded votes show some opposition in the House, but no committee-level dissent is reflected in the available materials.